Abstract
Anti-TNF monoclonal antibodies are commonly used in IBD treatment. However, some patients are not responsive to this therapy and the concomitant use of this biologics with other immunosuppressive drugs that ameliorate treatment leads to important adverse effects. On the other hand, the levels of the hormone dehydroepiandrosterone (DHEA) are reduced in CD and UC patients, while the supplem…